Literature DB >> 10357829

Oxidation of LDL in baboons is increased by alcohol and attenuated by polyenylphosphatidylcholine.

K P Navder1, E Baraona, M A Leo, C S Lieber.   

Abstract

Alcohol taken in moderation may prevent atherosclerosis, whereas heavy drinking has the opposite effect, in part by promoting oxidation of low density lipoproteins (LDL), a pathogenetic factor in atherogenesis. We assess here: 1 ) whether similar alterations can be reproduced in baboons fed 50% of energy as ethanol (the average intake of alcoholics) for 7- 8 years, and 2 ) whether such alterations are affected by supplementation with polyenylphosphatidylcholine (PPC), a mixture of polyunsaturated phosphatidylcholines, shown to prevent alcoholic fatty liver, fibrosis, and cirrhosis. Ten animals were given the ethanol-containing diet and ten were pair-fed isocaloric control diets. In half of the pairs, the diets were supplemented with 2.8 g of polyenylphosphatidylcholine/1000 kcal. Alcohol feeding increased LDL-lipoperoxides and made LDL-proteins more negatively charged, changes that were attenuated or prevented by PPC. The oxidizability of LDL was determined in vitro by the formation of conjugated dienes after oxidation with copper. Alcohol shortened the lag time (which measures LDL antioxidant capacity); this effect was normalized by PPC supplementation. By contrast, PPC produced no changes in the controls. Thus polyenylphosphatidylcholine, by markedly attenuating the ethanol-induced increase in LDL oxidation, opposes one of the effects whereby alcohol promotes atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357829

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  2 in total

1.  Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers.

Authors:  Tanushree Bose; Juan Carlos Lopez Alvarenga; M Elizabeth Tejero; V Saroja Voruganti; J Michael Proffitt; Jeanne H Freeland-Graves; Shelley A Cole; Anthony G Comuzzie
Journal:  J Med Primatol       Date:  2009-08-21       Impact factor: 0.667

2.  Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia.

Authors:  Igor V Maev; Aleksey A Samsonov; Liudmila K Palgova; Chavdar S Pavlov; Elena N Shirokova; Elena I Vovk; Kirill M Starostin
Journal:  BMJ Open Gastroenterol       Date:  2020-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.